Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis

NCT01502137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
End-Stage Renal Disease
Healthy

Interventions

DRUG: somatropin
DRUG: somatropin

Sponsor

Novo Nordisk A/S